Trial NCT05178862

View at ClinicalTrials.gov 
Org. Study IDs: SCY-078-302
Secondary IDs: MSG-20

Last trial update was posted on 2023-11-18

MeSH Interventions

Anidulafungin Caspofungin Echinocandins Fluconazole Ibrexafungerp Micafungin

MeSH Conditions

Candidemia Candidiasis Candidiasis, Invasive

Other Conditions


Stopping Reasons

During a review of manufacturing equipment and cleaning activities at a supplier that manufactured study drug for this study, SCYNEXIS was made aware of potential cross-contamination risk with a non-antibacterial beta-lactam drug substance.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID